West Pharmaceutical
302 hedge funds and large institutions have $6.72B invested in West Pharmaceutical in 2017 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 118 increasing their positions, 96 reducing their positions, and 41 closing their positions.
2,006% more call options, than puts
Call options by funds: $1.01M | Put options by funds: $48K
23% more repeat investments, than reductions
Existing positions increased: 118 | Existing positions reduced: 96
6% more capital invested
Capital invested by funds: $6.36B → $6.72B (+$352M)
2.76% more ownership
Funds ownership: 91.55% → 94.31% (+2.8%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
10% less first-time investments, than exits
New positions opened: 37 | Existing positions closed: 41
2% less funds holding
Funds holding: 309 → 302 (-7)
Top Buyers
| 1 |
William Blair Investment Management
Chicago,
Illinois
|
+$80.4M |
| 2 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$76.2M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$48.1M |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$47.1M |
| 5 |
1832 Asset Management
Toronto,
Ontario, Canada
|
+$33.7M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$65.5M |
| 2 |
BlackRock
New York
|
-$29.8M |
| 3 |
O
OppenheimerFunds
New York
|
-$28.7M |
| 4 |
CWAM
Columbia Wanger Asset Management
Chicago,
Illinois
|
-$21.4M |
| 5 |
Morgan Stanley
New York
|
-$19.8M |
WST Hedge Fund Activity: Q3 2017 in Review
302 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q3 2017, worth a combined $6.72B — up 5.5% from $6.36B a quarter earlier.
Sellers outnumbered buyers: 41 funds closed out of WST and 37 opened new positions — a net loss of 4 holders — while 96 trimmed existing stakes and 118 added.
The largest buyer was William Blair Investment Management, opening a new position worth an estimated $80.4M. The largest seller was Millennium Management, cutting an estimated $65.5M.
- 302 institutional investors held West Pharmaceutical (WST) as of Q3 2017, down from 309 in Q2 2017.
- Funds reported $6.72B of West Pharmaceutical stock for Q3 2017, up 5.5% quarter-over-quarter.
- 37 funds opened new West Pharmaceutical positions in Q3 2017 and 41 closed out, a net change of -4 holders.
- The largest West Pharmaceutical buyer in Q3 2017 was William Blair Investment Management, an estimated $80.4M added.
- The largest West Pharmaceutical seller in Q3 2017 was Millennium Management, an estimated $65.5M sold.
Based on aggregated 13F filings for Q3 2017.